Application of Tongbian Scraping Combined with Suhuang Zhike Capsule in Chronic Obstructive Pulmonary Disease

Objective: This study investigates the application of Tongbian scraping combined with Suhuang Zhike capsule in chronic obstructive pulmonary disease (COPD). Methods: 43 patients with COPD treated with Tongbian scraping combined with Suhuang Zhike capsule from January 2023 to June 2023 in our hospital were allocated into the observation group, and 53 patients with COPD treated with Suhuang Zhike capsule were assigned into the control group during the same period. The clinical efficacy and adverse reactions in the two groups were compared, and the changes of traditional Chinese medicine (TCM) syndrome score, lung and immune functions, and 6-min walking distance were observed before and after treatment. Results: The total effective rate of clinical efficacy in the observation group was higher than that in the control group (p < 0.05). After treatment, TCM syndrome score, COPD evaluation test score, and CD8+ level were decreased in both groups (p < 0.05), and these in the observation group were lower than those in the control group (p < 0.05). The forced expiratory volume in the first second (FEV1), the predicted percentage of FEV1 in FEV, the levels of CD4+ and CD4+/CD8+, and 6-min walking distance in both groups were elevated (p < 0.05), and these in the observation group were increased when compared with those in the control group (p < 0.05). There was no significant difference in nausea, vomiting, constipation, dizziness, and total adverse reactions between the two groups (p > 0.05). Conclusions: Tongbian scraping combined with Suhuang Zhike capsule has good clinical effect in the treatment of COPD, which can alleviate clinical symptoms, improve lung and immune functions, and enhance the activity tolerance, with good safety.